Peter Siesel is the Chief Commercial Officer at IsoPlexis. Before joining IsoPlexis in 2020, Peter held a variety of sales, marketing and management roles at Tecan, a global provider of automated workflow solutions in the life science and clinical diagnostics markets. As one of Tecan’s first employees, Peter had a significant impact on the organization’s growth, including product and applications development, intellectual property, strategic partnerships and the creation of state-of-the-art sales process methodologies. Peter oversaw triple digit sales growth as Tecan took advantage of the global genomics revolution. Under Peter’s leadership, the United States became the market leader in liquid handling automation for key market segments such as; bioprocessing, cell culture, genomics, molecular diagnostics and cfDNA. In his last position with Tecan, Peter was Senior Vice President of Sales, where he was responsible for commercialization in the Americas.